NO20024796L - Preparater for anvendelse som penetrasjonsfremmere i transdermale formuleringer for meget lipofile aktive bestanddeler - Google Patents
Preparater for anvendelse som penetrasjonsfremmere i transdermale formuleringer for meget lipofile aktive bestanddelerInfo
- Publication number
- NO20024796L NO20024796L NO20024796A NO20024796A NO20024796L NO 20024796 L NO20024796 L NO 20024796L NO 20024796 A NO20024796 A NO 20024796A NO 20024796 A NO20024796 A NO 20024796A NO 20024796 L NO20024796 L NO 20024796L
- Authority
- NO
- Norway
- Prior art keywords
- active ingredients
- preparations
- transdermal formulations
- highly lipophilic
- lipophilic active
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10019171A DE10019171A1 (de) | 2000-04-07 | 2000-04-07 | Zusammensetzungen zur Verwendung als Penetrationsverstärker in transdermalen Formulierungen für hoch lipophile Wirkstoffe |
PCT/EP2001/003896 WO2001076608A1 (en) | 2000-04-07 | 2001-04-05 | Compositions for use as penetration promoters in transdermal formulations for highly lipophilic active ingredients |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20024796D0 NO20024796D0 (no) | 2002-10-04 |
NO20024796L true NO20024796L (no) | 2002-12-06 |
Family
ID=7639165
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20024796A NO20024796L (no) | 2000-04-07 | 2002-10-04 | Preparater for anvendelse som penetrasjonsfremmere i transdermale formuleringer for meget lipofile aktive bestanddeler |
Country Status (8)
Country | Link |
---|---|
US (1) | US20030157155A1 (no) |
EP (1) | EP1267884B1 (no) |
JP (1) | JP2003530354A (no) |
AT (1) | ATE279199T1 (no) |
AU (1) | AU2001260180A1 (no) |
DE (2) | DE10019171A1 (no) |
NO (1) | NO20024796L (no) |
WO (1) | WO2001076608A1 (no) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6503894B1 (en) | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
DE10107663B4 (de) * | 2001-02-19 | 2004-09-09 | Lts Lohmann Therapie-Systeme Ag | Testosteronhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung |
DE10159217A1 (de) | 2001-11-27 | 2003-06-05 | Schering Ag | 17alpha-Alkyl-17ß-oxy-estratriene und Zwischenprodukte zu deren Herstellung, Verwendung der 17alpha-Alkyl-17ß-oxy-estratriene zur Herstellung von Arzneimitteln sowie pharmazeutische Präparate |
JP5006196B2 (ja) | 2005-08-01 | 2012-08-22 | 久光製薬株式会社 | 経皮または経粘膜投与のためのアジュバントおよび製剤 |
DE102005050431A1 (de) * | 2005-10-21 | 2007-04-26 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System zur Verabreicherung lipophiler und/oder wenig hautpermeabler Wirkstoffe |
GB0704846D0 (en) * | 2007-03-13 | 2007-04-18 | Futura Medical Dev Ltd | Topical pharmaceutical formulation |
US8383865B2 (en) * | 2007-04-17 | 2013-02-26 | Codman & Shurtleff, Inc. | Curcumin derivatives |
EP2749552B1 (en) * | 2007-04-17 | 2015-11-18 | Codman & Shurtleff, Inc. | Curcumin-resveratrol hybrids |
US7745670B2 (en) * | 2008-06-27 | 2010-06-29 | Codman & Shurtleff, Inc. | Curcumin-Resveratrol hybrid molecule |
US7985776B2 (en) | 2008-06-27 | 2011-07-26 | Codman & Shurtleff, Inc. | Iontophoretic delivery of curcumin and curcumin analogs for the treatment of Alzheimer's Disease |
US7723515B1 (en) * | 2009-01-26 | 2010-05-25 | Codman & Shurtleff, Inc. | Methylene blue—curcumin analog for the treatment of alzheimer's disease |
US20100286585A1 (en) * | 2009-01-26 | 2010-11-11 | Codman & Shurtleff, Inc. | Shunt Delivery of Curcumin |
EP2258375A1 (de) | 2009-06-04 | 2010-12-08 | Bayer Schering Pharma Aktiengesellschaft | 17B-alkyl-17alpha-oxy-estratriene |
JP6114401B2 (ja) | 2013-10-31 | 2017-04-12 | 久光製薬株式会社 | アジュバント組成物、これを含むアジュバント製剤、及びキット |
Family Cites Families (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4552872A (en) * | 1983-06-21 | 1985-11-12 | The Procter & Gamble Company | Penetrating topical pharmaceutical compositions containing corticosteroids |
US4559054A (en) * | 1984-08-09 | 1985-12-17 | Research Corporation | Rate-controlled drug release system |
US4789547A (en) * | 1987-06-17 | 1988-12-06 | Warner-Lambert Company | Transdermal matrix system |
ES2081823T3 (es) * | 1988-10-27 | 1996-03-16 | Schering Ag | Agente para la aplicacion transdermica, que contiene gestoden. |
DE3910578A1 (de) * | 1989-03-29 | 1990-10-04 | Schering Ag | Mittel zur transdermalen applikation enthaltend gestoden |
US5026556A (en) * | 1988-11-10 | 1991-06-25 | Norwich Eaton Pharmaceuticals, Inc. | Compositions for the transdermal delivery of pharmaceutical actives |
US4891377A (en) * | 1988-12-02 | 1990-01-02 | Board Of Regents Acting For And On Behalf Of University Of Michigan | Transdermal delivery of the narcotic analgesics etorphine and analogs |
US5788983A (en) * | 1989-04-03 | 1998-08-04 | Rutgers, The State University Of New Jersey | Transdermal controlled delivery of pharmaceuticals at variable dosage rates and processes |
US4956171A (en) * | 1989-07-21 | 1990-09-11 | Paco Pharmaceutical Services, Inc. | Transdermal drug delivery using a dual permeation enhancer and method of performing the same |
AR246186A1 (es) * | 1989-11-17 | 1994-07-29 | Beta Pharm Co | Procedimiento para fabricar un dispositivo para administrar estradiol por via transdermica. |
JPH05946A (ja) * | 1991-06-27 | 1993-01-08 | Nichiban Co Ltd | ケトチフエン含有経皮吸収製剤 |
DE4210165A1 (de) * | 1991-07-30 | 1993-02-04 | Schering Ag | Transdermale therapeutische systeme |
US5676968A (en) * | 1991-10-31 | 1997-10-14 | Schering Aktiengesellschaft | Transdermal therapeutic systems with crystallization inhibitors |
WO1993014727A1 (en) * | 1992-01-31 | 1993-08-05 | Cygnus Therapeutic Systems | Transdermal administration of buprenorphine in the form of ion pair complexes |
JP2960832B2 (ja) * | 1992-05-08 | 1999-10-12 | ペルマテック テクノロジー アクチェンゲゼルシャフト | エストラジオールの投与システム |
EP0581587A3 (en) * | 1992-07-31 | 1995-05-17 | Tanabe Seiyaku Co | Base material for transdermal administration. |
DE4329242A1 (de) * | 1993-08-26 | 1995-03-02 | Schering Ag | Mittel zur transdermalen Applikation enthaltend Gestodenester |
PL178394B1 (pl) * | 1994-02-04 | 2000-04-28 | Scotia Lipidteknik Ab | Lipofilowy preparat nośnikowy i środek farmaceutyczny zawierający lipofilowy preparat nośnikowy |
CN1106259A (zh) * | 1994-02-05 | 1995-08-09 | 日东制药株式会社 | 含有作为有效成分的丙酸类非类固醇性药物的新颖消炎镇痛外用凝胶制剂 |
DE4405899A1 (de) * | 1994-02-18 | 1995-08-24 | Schering Ag | Mittel zur transdermalen Applikation enthaltend Desogestrel |
JPH07252150A (ja) * | 1994-03-14 | 1995-10-03 | T T S Gijutsu Kenkyusho:Kk | オザグレル含有経皮吸収型製剤 |
JPH08245377A (ja) * | 1995-03-15 | 1996-09-24 | Yamanouchi Pharmaceut Co Ltd | 経皮吸収用製剤 |
DE19613698A1 (de) * | 1995-07-17 | 1997-01-23 | Schering Ag | Mittel zur transdermalen Applikation enthaltend Ester des 13-Ethyl-17ß-hydroxy-11-methylen-18,19-dinor-17alpha-pregn-4-en-20-yn-3-ons |
IT1283102B1 (it) * | 1996-06-06 | 1998-04-07 | Permatec Nv | Composizione terapeutica per la somministrazione transdermica di un principio attivo estrogeno o progestinico o di loro miscele |
US5669377A (en) * | 1996-07-05 | 1997-09-23 | Fenn; Arthur C. | Nasal band and method for improved breathing |
DE19629468A1 (de) * | 1996-07-11 | 1998-01-15 | Schering Ag | Transdermale therapeutische Systeme |
DE19635525A1 (de) * | 1996-08-20 | 1998-02-26 | Schering Ag | 7alpha-(xi-Aminoalkyl)-estratriene, Verfahren zu deren Herstellung, pharmazeutische Präparate, die diese 7alpha(xi-Aminoalkyl-estratriene enthalten sowie deren Verwendung zur Herstellung von Arzneimitteln |
US5866560A (en) * | 1996-08-20 | 1999-02-02 | Schering Ag | 7α-(ξ-aminoalkyl)-estratrienes, process for their production, pharmaceutical preparations which contain these 7α-(ξ-aminoalkyl)-estratrienes as well as their use for the production of pharmaceutical agents |
DE19842123C1 (de) * | 1998-09-05 | 2000-07-13 | Schering Ag | 11beta-Fluor-7alpha-(14,14,15,15,15-pentafluor-6- methyl-10-thia-6-azapentadecyl)estra-1,3,5(10)- trien-3,17beta-diol als kristallines Ansolvat |
-
2000
- 2000-04-07 DE DE10019171A patent/DE10019171A1/de not_active Withdrawn
-
2001
- 2001-04-05 US US10/240,825 patent/US20030157155A1/en not_active Abandoned
- 2001-04-05 AU AU2001260180A patent/AU2001260180A1/en not_active Abandoned
- 2001-04-05 AT AT01933793T patent/ATE279199T1/de not_active IP Right Cessation
- 2001-04-05 EP EP01933793A patent/EP1267884B1/en not_active Expired - Lifetime
- 2001-04-05 WO PCT/EP2001/003896 patent/WO2001076608A1/en active IP Right Grant
- 2001-04-05 JP JP2001574124A patent/JP2003530354A/ja active Pending
- 2001-04-05 DE DE60106406T patent/DE60106406T2/de not_active Expired - Fee Related
-
2002
- 2002-10-04 NO NO20024796A patent/NO20024796L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1267884B1 (en) | 2004-10-13 |
DE10019171A1 (de) | 2001-10-18 |
US20030157155A1 (en) | 2003-08-21 |
DE60106406T2 (de) | 2006-02-23 |
WO2001076608A1 (en) | 2001-10-18 |
DE60106406D1 (de) | 2004-11-18 |
EP1267884A1 (en) | 2003-01-02 |
AU2001260180A1 (en) | 2001-10-23 |
JP2003530354A (ja) | 2003-10-14 |
ATE279199T1 (de) | 2004-10-15 |
NO20024796D0 (no) | 2002-10-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20024796L (no) | Preparater for anvendelse som penetrasjonsfremmere i transdermale formuleringer for meget lipofile aktive bestanddeler | |
DE19581804T1 (de) | Pharmazeutische Zusammensetzungen | |
ATE279209T1 (de) | Injizierbare pharmazeutische zusammensetzung zur systemischen verabreichung pharmakologisch aktiver wirkstoffe enthaltend mittelkettige triglyceride | |
AR046878A1 (es) | Agente endoparasiticida para administracion topica | |
ATE243524T1 (de) | Zusammensetzungen enthaltend boswellia-extrakte | |
ATE396694T1 (de) | O/w-emulsionen mit unpolaren wirkstoffen | |
ITMI913127A1 (it) | Composizioni per uso dermatologico e cosmetico | |
DE60135927D1 (en) | Nd | |
DK1151755T3 (da) | Farmaceutisk præparat indeholdende cyclosporin som aktiv bestanddel | |
ES2196645T3 (es) | Composiciones transparentes para el cuidado de la piel. | |
WO2007051830A3 (en) | Composition for the transdermal administration of physiologically active agents | |
ATE79277T1 (de) | Eine pharmazeutische zusammensetzung angepasst an die transdermale applikation eines opioids. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |